Cash & equivalents increased 167.5%
Cash & equivalents changed +167.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +167.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -70.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +22.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +13.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Working capital changed +22.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +272 basis points from the comparable as-filed period.
Current liabilities changed +20.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory / revenue changed -715 basis points from the comparable as-filed period.
Receivables / revenue changed -5808 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed +498 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed -87 basis points from the comparable as-filed period.
Stock-based compensation changed +23.9% from the comparable as-filed period.
Revenue changed +1.3% from the comparable as-filed period.
Research & development changed +8.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed -9.4% from the comparable as-filed period.
Inventory changed -7.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +83 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +31 basis points from the comparable as-filed period.
Gross profit changed +6.8% from the comparable as-filed period.
Cost of revenue changed -4.2% from the comparable as-filed period.
Current ratio changed +1.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed +85.6% from the comparable as-filed period.
Operating margin changed +643 basis points from the comparable as-filed period.
Gross margin changed +486 basis points from the comparable as-filed period.
Trade receivables changed -59.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +84.7% from the comparable as-filed period.
Inventory / revenue changed -2076 basis points from the comparable as-filed period.
Working capital changed +25.3% from the comparable as-filed period.
Capital expenditure changed +56.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -3799 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +290.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed +310.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Revenue changed +10.3% from the comparable as-filed period.
Current assets changed +19.4% from the comparable as-filed period.
Working capital / assets changed +799 basis points from the comparable as-filed period.
Operating cash-flow margin changed +5225 basis points from the comparable as-filed period.
Free-cash-flow margin changed +5183 basis points from the comparable as-filed period.
Inventory changed -14.4% from the comparable as-filed period.
Gross profit changed +20.6% from the comparable as-filed period.
Capex / revenue changed +42 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed +10.4% from the comparable as-filed period.
R&D / revenue changed -213 basis points from the comparable as-filed period.
Current ratio changed +15.9% from the comparable as-filed period.
Stock-based compensation changed +14.2% from the comparable as-filed period.
Research & development changed -7.7% from the comparable as-filed period.
Shares outstanding changed -0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
SBC / revenue changed +5 basis points from the comparable as-filed period.
Current liabilities changed +3.0% from the comparable as-filed period.
Cost of revenue changed -0.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.